In this study, two human breast cancer cell lines, SK-BR-3 and BT474, with high expression levels of the HER2 protein, and a gastric cancer cell line, N87, also overexpressing the HER2 antigen, were employed. The gene discussed is ERBB2; the disease is breast carcinoma.